University of Michigan Comprehensive Cancer Center researchers have developed a new potential drug candidate that shows promise against a rare type of blood cancer, as well as potential in prostate cancer. The new drug candidate showed potential in laboratory studies against a rare type of acute leukemia. Additionally, separate studies …